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Abstract The elongation cycle of protein synthesis on ribo-
somes is catalyzed by the elongation factors EF-Tu and EF-G. A
thorough crystallographic analysis of the structures of the
different functional states of EF-Tu has been made. Further-
more, the structure of EF-G:GDP is the form of EF-G that
dissociates from the ribosome. Since it mimics the structure of
the ternary complex of EF-Tu:GTP with aminoacyl-tRNA,
which subsequently binds to the ribosome, EF-G:GDP leaves an
imprint on the ribosome for the ternary complex. In addition,
electron cryomicroscopy studies of ribosomes with tRNA as well
as the ternary complex bound are beginning to give a solid
structural basis for the functional description of elongation.
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1. Introduction
The transformation of genetic information on DNA into
functional proteins in a living cell is a complicated process
involving many RNA and protein molecules. One part is the
translation of the transcribed information on mRNA on the
ribosome which is a large complex of ribosomal RNA and
protein. Protein synthesis is catalyzed by protein factors, some
of which are GTPases (G-proteins). Translation is divided
into three phases: initiation, elongation and termination. Ex-
tensive structural information has been obtained for the elon-
gation factors. Much structural information has also been
obtained for ribosomal proteins and fragments of ribosomal
RNA [1]. Structural information about complete ribosomes in
di¡erent functional states has been obtained by electron cry-
omicroscopy (cryo-EM) [2^5] and for ribosomal subunits by
X-ray crystallography [6].
This review is based on the structural information about the
elongation factors shedding light on the functional steps in the
elongation cycle of protein biosynthesis. We will mostly con-
centrate on a few relevant points arising from the structural
information.
2. The ribosome
Cryo-EM has provided a new level of structural acquaint-
ance with the bacterial ribosome at resolutions better than 20
Aî [2^4]. The structural studies of the ribosomal subunits have
identi¢ed channels and structural details which yet remain
somewhat anonymous, but the localization of proteins and
rRNA is in progress [7^9]. The A, P, and E binding sites
for the tRNAs have been located [2,3] and the binding of
elongation factors is in progress [4]. The contacts of the
tRNAs with the 30S subunit have given a clear identi¢cation
of the decoding site while the acceptor end of the tRNA has
helped to locate the peptidyl transfer site [2,3]. The analysis of
the binding of elongation factor Tu (EF-Tu) to the ribosome
[4] has furthermore resolved an old con£ict concerning the
position on the ribosome of the aminoacylated CCA end of
the tRNA when bound to EF-Tu. It is evident that the clas-
sical factor binding site below the L7/L12 stalk on the large
subunit is the factor binding site and that the acceptor end of
the tRNA is associated with the factor as discussed below.
Thus, as long as EF-Tu binds to the ribosome the aminoacyl
part of the tRNA is nowhere near the peptidyl transfer site.
The binding of elongation factor G (EF-G) will be the next
challenge for cryo-EM. Since the factors, like all G-proteins,
go through conformational changes in their functional cycle
(see below) it can be expected that they display several con-
formations on the ribosome.
3. Elongation factor Tu
EF-Tu:GTP protects the aminoacyl-tRNA (aa-tRNA)
against hydrolysis, and assists the ribosome in making a cor-
rect interaction between the current codon on the mRNA in
the ribosomal A site and the anticodon of aa-tRNA [10].
Upon such a correct interaction the ribosome stimulates the
GTP hydrolysis of EF-Tu, after which EF-Tu:GDP is re-
leased from the ribosome. The antibiotic kirromycin will in-
hibit this release mechanism. EF-Tu:GDP is recycled into its
active form EF-Tu:GTP by the nucleotide exchange factor,
EF-Ts.
All functionally relevant complexes of EF-Tu have been
studied. Thus the structures of EF-Tu:GDPNP from both
Thermus thermophilus [11] and T. aquaticus [12] have been
determined. GDPNP is a non-hydrolyzable analogue of
GTP. Recently, the structures of intact EF-Tu:GDP from
T. aquaticus [13] and Escherichia coli [13,14] have been pub-
lished. EF-Tu functions as a molecular switch by altering the
relative orientation of the nucleotide binding domain 1 (or G-
domain) to domains 2 and 3 which are held together by strong
interactions [11]. Thus the activation or inactivation by re-
charging EF-Tu with GTP or by hydrolyzing the GTP is
accompanied by very large conformational changes of these
two parts relative to each other [11,12].
The nucleotide exchange achieved by the complex of EF-
Tu:EF-Ts is apparently performed by physically separating
the two functional parts of EF-Tu as has been observed in
FEBS 20388 29-6-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 6 2 4 - 3
*Corresponding author. Fax: (45) 8612 3178.
E-mail: jnb@imsb.au.dk
FEBS 20388 FEBS Letters 430 (1998) 95^99
structures of the proteins from E. coli ([15]; S. Thirup, person-
al communication) and T. thermophilus [16]. These two struc-
tures raise as many questions as answers are given.
The structure of the monomer of EF-Ts from E. coli [15]
has an internal pseudo-two-fold symmetry, which is re£ected
in the sequence. The N-terminal part of EF-Ts interacts with
domain 1 of EF-Tu, while the C-terminal part interacts with
domain 3. The C-terminal part has a protruding helix hairpin,
which forms part of the interface to another pseudo-symmet-
ric monomer. The resulting dimer of EF-Ts (consisting of four
pseudo-related units) thus has two binding sites for EF-Tu on
the same surface of the dimer. The structure of the fully sym-
metric dimer of EF-Ts from T. thermophilus [16] has a struc-
ture which is similar to the pseudo-symmetric monomer of
EF-Ts from E. coli. In fact the monomer from T. thermophilus
resembles most the C-terminal part of EF-Ts from E. coli,
including the protruding helix hairpin. The symmetric dimer
(consisting of two identical units) therefore also exposes two
identical binding sites for EF-Tu, but now on opposite surfa-
ces. Although the overall structures of the two complexes are
very di¡erent, both structures can be said to have a stoichi-
ometry of EF-Tu:(EF-Ts)2 :EF-Tu.
Whether these structures really represent functional states is
at the moment hard to tell, but if they do not, what is then the
function of the protruding helix hairpin? Although the struc-
tures show how EF-Ts modi¢es the local structures of many
of the nucleotide binding loops, the detailed mechanism of
nucleotide exchange is not clear. EF-Ts from E. coli has a
C-terminal extension, which mimics the structure of the e¡ec-
tor loop of EF-Tu (S. Thirup, personal communication). Why
does it do that in the E. coli complex while this is not needed
in the T. thermophilus complex?
The structure of the ternary complex of Phe-tRNA from
yeast and EF-Tu:GDPNP from T. aquaticus [17] shows a very
elongated complex, with the anticodon of Phe-tRNA pointing
away from EF-Tu. The amino acid of Phe-tRNA is held in a
pocket between domains 1 and 2 by hydrogen bonds to the
main chain of the protein. The surface of domain 2 has a
speci¢c binding pocket for the terminal A-base of tRNA
[18] while residues from all three domains recognize the 5P-
phosphate. The backbone structure of the T-stem helix is
bound to the surface of domain 3. The structures of both
the active EF-Tu and the tRNA are very little altered during
complex formation [17]. It has been shown recently that the
crystal structure is similar to the structure found in solution
[19].
The structure of the ternary complex of E. coli Cys-tRNA
and T. aquaticus EF-Tu:GDPNP has very recently been de-
termined [20]. The overall structure is very similar to that of
the ternary complex with yeast Phe-tRNA [17], although the
crystal packings are very di¡erent (Fig. 1). This structure de-
termination con¢rms the basic assumption that structures of
di¡erent tRNAs can e⁄ciently be obtained in complex with
EF-Tu:GDPNP. The Cys-tRNA is two nucleotides shorter
than the canonical yeast Phe-tRNA, with deletions in the
D-loop and in the variable loop. This tRNA structure displays
some unusual features such as a unique G15 :G48 pair instead
of the generally conserved ‘Levitt pair’, and such as two A-
rich triples s4U8 :A14 :A46 and A9 :A13 :A22. The structure of
EF-Tu:GDPNP in this complex is generally very similar to
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Fig. 1. Comparison of ternary complexes of EF-Tu with Phe-tRNA and Cys-tRNA. To the left is shown the complex of yeast Phe-tRNA and
T. aquaticus EF-Tu:GDPNP. To the right is the structure of the complex of E. coli Cys-tRNA and T. aquaticus EF-Tu:GDPNP. The domains
of EF-Tu are shown in cartoons in shadings of dark gray to light gray from the N- to the C-terminal, while the tRNAs are shown in backbone
tracings only. Notice that there are local variations of the structure of Cys-tRNA as compared to Phe-tRNA. Notice also that the anticodon
helix of Cys-tRNA makes a larger angle with the rest of the tRNA. The picture is drawn with MOLSCRIPT [42].
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the structure of the free factor. However, it is evident that side
chains in contact with Cys-tRNA adapt to the local variations
of the RNA structure.
The detailed mechanism of the GTP hydrolysis of EF-Tu
has been a puzzle for some time. The main reason is that EF-
Tu when compared to other G-proteins has a very low intrin-
sic GTPase activity [21]. EF-Tu works as a time-delayed mo-
lecular switch, and the GTPase activity is thus highly stimu-
lated when the ternary complex interacts with the ribosome.
Some information can be obtained by similarity with other G-
proteins where structures with the transition state inhibitor
AlF3 have been obtained for the hetero-trimeric G-proteins
[22,23] and for the ras-p21 protein [24]. Very elegant experi-
ments strongly suggest that the Q-phosphate itself is activating
a catalytic water [25]. The structural evidence indicates that an
Arg residue is stabilizing the transition state. In the hetero-
trimeric G-proteins this Arg is an internal residue found at the
end of the e¡ector loop, while for ras-p21, which does not
have an Arg residue at this position, a similar stabilizing Arg
is supplied from a GTPase activating protein [24].
In EF-Tu the situation is a little more complex. Arg59 of
EF-Tu aligns with the internal residue in the hetero-trimeric
G-proteins. However, mutations of this residue have very little
e¡ect on the GTP hydrolysis. Mutating Arg59 rather seems to
in£uence binding of aa-tRNA [26,27]. Moreover, it has not
been possible to use AlF3 as a transition state inhibitor for
EF-Tu (or EF-G) [28]. It is thus possible that the ribosome is
providing a transition state stabilizing residue.
Crystals have recently been obtained of the quaternary
complex of Phe-tRNA:kirromycin:EF-Tu:GDPNP [29]. A
model for the overall structure has been determined, although
at the present state of re¢nement a model for kirromycin
cannot be unambiguously placed in density. However, resid-
ual densities are found in a cleft between domains 1 and 3 of
EF-Tu as predicted from the positions of kirromycin resistant
mutants [30]. The overall e¡ect of the kirromycin is to bend
domain 1 towards the tRNA. The structure of this quaternary
complex is more closely similar to the density observed for the
kirromycin inhibited ternary complex on the ribosome in the
cryo-EM investigation [4].
4. Elongation factor G
The structure of EF-G is composed of four domains in
addition to the G-domain. The structure of EF-G:GDP
[31,32] from T. thermophilus can be accurately superimposed
on that of the ternary complex of Phe-tRNA and EF-
Tu:GDPNP [17]. Apart from an insertion in EF-G of a sub-
domain in domain 1 and an insertion of a L-hairpin between
domains 1 and 2, these domains have folds very similar to
those of the corresponding domains in EF-Tu [33]. The rest of
the structure of EF-G, domains 3, 4 and 5, mimics the tRNA
of the ternary complex [34]. Since EF-G:GDP is the form that
dissociates from the ribosome it is conceivable that EF-
G:GDP leaves behind it an imprint on the ribosome suitable
for the binding of the ternary complex [35].
In the case of EF-G the structure of the nucleotide free
protein is very similar to the complex with GDP [32]. The
structure of the complex with GTP remains di⁄cult to crys-
tallize. Thus we are left with indirect observations with regard
to the structure of this complex and the conformational
changes caused by GTP hydrolysis. One important piece of
information in this regard is the locations of the mutations
that lead to fusidic acid resistance for EF-G and their com-
parison to kirromycin resistance mutations in EF-Tu. These
two antibiotics cause EF-G and EF-Tu respectively to stick to
the ribosome after GTP hydrolysis. The large conformational
change that causes EF-Tu to dissociate from the tRNA and
the ribosome upon GTP cleavage leads to the loss of contact
of helix C of the G-domain with the C-terminal domain 3.
This general area is the binding site of kirromycin as described
above. This is also the location of many of the kirromycin
resistant mutations in EF-Tu [36]. It is possible that some of
these prevent the binding of kirromycin, but it is also possible
that some of them permit the conformational change despite
the fact that kirromycin is bound. In the EF-G:GDP complex
helix C of the G-domain also interacts with the C-terminal
domain (domain 5). The binding site of fusidic acid is not
known, but many fusidic acid resistant mutants are found in
this area [37]. Thus it seems likely that the changes in domain
contacts caused by GTP cleavage would involve the same face
of the G-domain. However, one signi¢cant di¡erence is that
the macromolecular mimicry involves the ribosome binding
complex of EF-Tu and the ribosome dissociating complex of
EF-G.
5. The binding of elongation factors to the ribosome
A ternary complex of EF-Tu inhibited by kirromycin has
been visualized on the surface of the ribosome using cryo-EM
[4]. Comparison with a similar model of the ribosome with
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Fig. 2. A schematic representation of the binding states of tRNA
and elongation factors to the ribosome. The view is from above and
seen from the main protuberance side of the large subunit. The A,
P, E-sites for the tRNA are indicated as well as the binding site for
GTP hydrolyzing factors (F). a: tRNAs bound to the P- and E-
sites. b: The binding of EF-Tu:GTP and tRNA. The factor binds
to the classical factor binding site inside the L7/L12 stalk and the
tRNA, while it remains bound to EF-Tu, binds to the decoding site
of the 30S subunit. c: After GTP hydrolysis EF-Tu:GDP has disso-
ciated and the tRNA has moved completely into the A-site. d:
After peptidyl transfer EF-G binds to the ribosome and translocates
the tRNAs and the mRNA. The ¢gure illustrates the situation be-
fore EF-G:GDP dissociates from the ribosome.
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tRNAs in the P and A sites shows clear di¡erence densities in
a shape that can be interpreted as the ternary complex. It also
shows some local alteration of the position of the L7/L12
ribosomal protein, which is contacting EF-Tu near the GTP
binding site, thus most likely inducing a rapid GTP hydroly-
sis. The structure of the ternary complex stalled on the ribo-
some in a codon-anticodon testing state, with the tRNA anti-
codon in the A site of the 30S subunit, indicates that the
tRNA has to rotate so that the CCA-aa end can reach the
peptidyl transfer center.
The main contacts between the ribosome and EF-Tu are
between domain 1 and the 50S subunit and between domain
2 and the 30S subunit. This is interesting, because these two
domains are common between EF-Tu and EF-G [33], but also
because similar domains are present in all the translational G-
proteins [38]. The implication is that all will bind to the ribo-
some in the same way, and that the GTPase activity will be
stimulated by the same mechanism (Fig. 2).
One strange observation is that even the binding pocket for
the terminal A-base found in EF-Tu is preserved in EF-G
(Fig. 3). However, Glu271 of EF-Tu, which is important for
the speci¢c recognition of the A-base, is not conserved in EF-
G. It is interesting that residue Gly233 in T. aquaticus EF-Tu
(Gly222 in E. coli), which is found at the end of one of the two
loops making up the pocket, when mutated to Asp is the so-
called B0 kirromycin resistant mutant of EF-Tu [39].
Although the B0 mutant will allow kirromycin to bind to
the ternary complex (forming a quaternary complex), this
mutant has been shown to have impaired interaction with
the ribosome [39]. It is thus quite possible that the ribosome
by interacting with and modifying the local structure of this
pocket helps release the aa-tRNA from the ternary complex.
Also the EF-Tu mutant Gly292Val (Gly280 in E. coli), which is
located at the same surface of domain 2, has lowered a⁄nity
for the ribosome [40].
Whether the GTP hydrolysis of EF-G precedes transloca-
tion of the peptidyl tRNA from the A-site to the P-site or not
the EF-G:GDP complex is the dissociating form of the pro-
tein. Since this complex mimics the ternary complex of EF-
Tu:GTP with tRNA it is likely to make an ‘imprint’ on the
ribosome for the ternary complex [34,35]. The site it leaves
will ¢t for the ternary complex. This leads to the prediction
that EF-G:GDP will be bound to the ribosome very much
like the kirromycin inhibited ternary complex as observed by
cryo-EM. On the other hand, EF-G:GTP most likely will
bind with its G-domain to the factor binding site below the
L7/L12 stalk just like the ternary complex. However, the rest
of the molecule will be in a conformation di¡erent from that
of the ternary complex and thus not occupy any part of the A-
site for tRNA. Translocation will then take place by a con-
formational change in EF-G so that its tRNA mimicking part
will occupy the anticodon region of the A-site. Recent results
[41] suggest that this conformational change and translocation
is subsequent to the GTP hydrolysis.
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